Immunotherapy Weekly articles from September 2000

Immunotherapy Weekly archives from September 2000

Moderate Aggression in Men May Lead to Stronger Immune System.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Men who are moderately aggressive have stronger immune systems, finds a new study by a team of researchers from Pennsylvania State University and the University of Nebraska. Their study, "Human aggression...

Immune System Stimulant Enters Clinical Trials.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- LifeTime Pharmaceuticals (LifeTime), College Park, Maryland, announced the first U.S. clinical trials for Beta LT, a drug designed to stimulate the immune system. Future indications may include hepatitis C...

Adoptive Immunotherapy Successful Against PTLD.(post-transplant lymphoproliferative disease )
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Researchers in the United Kingdom have successfully used allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (CTL) to treat post-transplant lymphoproliferative disease (PTLD). "Autologous...

Antibody Therapy Highly Potent in Murine Model.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Researchers in Germany have created an antibody-based immunotherapy that produces promising results in animal cancer models. "The use of anti-CD3xantitumor bispecific Abs [antibodies] is an attractive and...

Mouse Study Suggests Interleukin-10 Administered Directly to Intestine is Safer, Cost-Effective.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- A new method for administering an anti-inflammatory protein may lead to better methods of treating inflammatory bowel disease (IBD). This painful condition, which includes Crohn's disease and ulcerative...

Adoptive Immunotherapy Enhanced by in vitro CD28/4-1BB Co-stimulation.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Adoptive immunotherapy can be enhanced by the in vitro co-stimulation of tumor reactive T cells, researchers in the United States reported. "Co-stimulation plays a critical role in T-cell activation and...

Immunotoxin Targets Mesothelin, Effective in Animal Models.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Immunotoxins targeting mesothelin may have therapeutic potential against ovarian cancer and malignant mesotheliomas. Researchers in the United States evaluated the anti-tumor activity of the immunotoxin...

Loratadine Superior to Fexofenadine for Treatment of Seasonal Allergy.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Loratadine provided better symptom relief from seasonal allergic rhinitis than fexofenadine in patients not responding to initial therapy, according to a study from the United States. "Nonsedating...

Experts Say Shots Should Be Used More Frequently in Allergic Asthma to Prevent Disease.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Patients who are diagnosed with allergic asthma, or with allergies such as hay fever or sinusitis that predispose them to asthma, should strongly consider allergy shots to prevent the development of new or...

Oral Administration of Grass Pollen Extract Well Tolerated and Improves Symptoms.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Data from a clinical trial show that oral administration of grass pollen extract in a tablet form was well tolerated in patients and resulted in a reduction of allergy symptoms, researchers in Italy reported....

Therapy Downregulates T Lymphocyte Activation.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Researchers in Turkey found that specific immunotherapy (SIT) downregulated T-lymphocyte activation in allergic asthmatics. "To evaluate the effect of SIT on T-lymphocyte subsets and its activation markers...

Generic Claritin Gets Delayed.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- The wait for a cheaper, generic form of the world's best selling allergy drug, Claritin, has been delayed. Drugmaker Schering-Plough Corp. said the U.S. Food and Drug Administration has approved a...

Triggers in the Classroom Mean Children Need to Take Special Precautions.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- A new survey by the American Academy of Allergy, Asthma, and Immunology (AAAAI) of allergists/ immunologists and school nurses showed that children with asthma and allergies often have reactions to triggers in...

Combined Antibody/Antivascular Therapy Eradicates Tumors in Mouse Model.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Promising results from preclinical studies with an antitumor protocol that combined antibody and antivascular therapy have spurred Phase I clinical trials, researchers in the United Kingdom reported. ...

Protein Halts White Blood Cells, May Result in New Treatments.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- A protein that reduces inflammation has been discovered by a group of University of British Columbia, Canada, researchers. The finding, reported in the August 18, 2000, issue of Science, may pave the way...

Collaboration Announced to Develop Antibody Therapeutics.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Medarex, Inc. (MEDX), Princeton, New Jersey, and Athersys, Inc., Cleveland, Ohio, announced a collaboration to develop therapeutics produced through the joint application of Medarex's HuMAb-Mouse technology...

Discovery in Proprietary DNA Delivery System Announced.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Supratek Pharma, Montreal, Quebec, Canada, announced at the American Chemical Society Annual Conference (ACS) that SP1017, its non-viral gene delivery system, significantly increases gene expression in muscle,...

Extracorporeal Photochemotherapy Successfully Treats GVHD.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Researchers in Italy used extracorporeal photochemotherapy (ECP) to successfully treat graft-vs-host disease (GVHD) in two bone marrow transplant patients. "We report our experience concerning two cases of...

Multikine Immunotherapy Clinical Trial OK'd for Czech Republic.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Cel-Sci Corp. (CVM), Vienna, Virginia, announced that the health authorities for the Czech Republic have granted the company permission to start a Phase II clinical trial in head and neck cancer patients with...

Immediate Response to Skin Test is Good Predictor of Anaphylaxis.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Researchers in France determined that immediate response to skin tests is a good predictor of an anaphylactic reaction to pneumococcal vaccine in children. "Pneumococcal vaccines are usually...

Patent Issued for Monoclonal Antibodies Binding to Prostate-Specific Membrane Antigen.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- BZL Biologics Inc., New York, New York, announced that Cornell University in New York was issued U.S. Patent No. 6,107,090 titled "Treatment and Diagnosis of Prostate Cancer. BZL holds the exclusive...

Cytokine-Activated Natural Killer Cells Tested in Patients.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Researchers in Germany tested the feasibility of the adoptive transfusion of allogeneic natural killer (NK) cells as therapy for renal cell carcinoma. "Patients with metastasized renal cell carcinoma have...

Phase II Efficacy Study Enrollment of C5 Complement Inhibitor Completed.
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Alexion Pharmaceuticals, Inc. (ALXN), New Haven, Connecticut, announced that it has completed patient enrollment with 5G1.1, its anti-inflammatory complement inhibitor drug candidate, in a Phase II efficacy...

Radioimmunotherapy Produces Promising Results in Clinical Trial.
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Radioimmunotherapy with 90y-labeled humanized LL2 (90Y-hLL2) anti-CD22 monoclonal antibody (MAb) has produced encouraging anti-tumor responses in refractory non-Hodgkin's lymphoma (NHL). Stephen L....

Birch-Pollen Immunotherapy Changes Cytokine Production in vitro.
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Birch-pollen immunotherapy changes cytokine production profiles in the early phase, report researchers in Sweden. "The kinetics of the immunological mechanisms during allergen-specific immunotherapy (IT)...

Knowledge of Activation-Induced Cell Death Provides Immunotherapeutic Prospects.
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- A better understanding of activation-induced cell death (AICD) may suggest new immunotherapeutic approaches to autoimmune diseases, AIDS, and transplantation medicine, researchers in Germany reported. ...

New Approach Shuts Down Immune Response, But Allows Cells to Function Properly.
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Howard Hughes Medical Institute (HHMI) researchers have discovered a way to shut down the inflammatory response in cells that spares related mechanisms that cells need in order to function properly. Their...

Non-Pathogenic Bacteria Block Inflammatory Response Pathway in Intestinal Tract.
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- A team of Emory University (Atlanta, Georgia) pathologists has discovered that non-pathogenic bacteria within the gastrointestinal tract may be responsible for blocking an immune pathway that otherwise could...

Preliminary Data Show Immunogene Therapy is Safe.
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Preliminary data from an ongoing Phase I clinical trial of immunogene therapy in melanoma patients suggest that the procedure is feasible and safe. "Dendritic cells (DCs) are potent antigen-presenting...

Naked DNA and Adenoviral Immunization Evaluated in Two-Year Study.
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Researchers in the United States and Bulgaria have conducted a two-year trial of immunotherapy for prostate cancer. "We have developed a method for inducing sustained autoimmunity against the human...

Chimeric Anti-Ganglioside GD3 Antibody KM871 Has Therapeutic Potential.
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Researchers in Japan have found that the chimeric anti-ganglioside GD3 antibody, KM871, has anticancer therapeutic potential. "KM871 is a chimeric antibody recognizing ganglioside GD3, which is one of the...

First Potential 'Universal' Vaccine Shows Promise in Lab.
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Results from preliminary laboratory studies provide the first functional evidence that developing a "universal" cancer vaccine might be possible, researchers from Duke University Medical Center and Geron...

Modified T Cells in HIV Patients Survive Long-Term in vivo.
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- According to a study from the United States, genetically modified T cells were capable of long-term survival in patients with HIV infection. "To study HIV specific cellular immunity in vivo, we...

Approval Advised to Conduct Australian Treatment Trial.
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Virax Holdings Limited (VHL), Melbourne, Australia, announced that Australia's Therapeutic Goods Administration (TGA) has advised approval of the company's Clinical Trials Exemption (CTX) application to...

Immunity Induced by Protein Conjugated to Immunostimulatory DNA.
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Protein conjugated to immunostimulatory DNA resulted in cell-mediated and humoral immunity against HIV, reported researchers in the United States. "Immunostimulatory DNA sequences (ISS) are a potent Th1...

Bone Marrow Transplants Show Promise Against Autoimmune Diseases.
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- New research bolsters the hope that doctors might one day be able to use bone marrow transplants to cure autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, and lupus. A few people with...

Investigational Treatment Shows Promise in Clinical Trials.(melanoma)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Increased emphasis has been placed on potential treatments for the late stages of melanoma. "Although it's best to catch skin cancer before it progresses, most people aren't diagnosed until their disease...

Ex vivo Immunotherapy Agreement Signed.
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Cytogen Corp. (CYTO), Princeton, New Jersey, announced that its has executed a sublicense agreement clarifying the rights of Northwest Biotherapeutics, Inc. to make and use prostate-specific membrane antigen...

Daily Interferon Alfacon-1 and Ribavirin Treatment Safe for Patients.
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Patients infected with the hepatitis C virus (HCV) can be treated with interferon alfacon-1 (Infergen, Amgen) on an accelerated schedule and also take the antiviral drug ribavirin without compromising safety,...

Grant Awarded to Study Preventive Monoclonal Antibody Use.
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Tanox Pharma B.V. announced that it has been awarded a grant of NLG 1,000,000 (approximately US$410,000) by SENTER, an agency of the Dutch Ministry of Economical Affairs, to study the use of 5D12, its...

Genetically Engineered Hypoallergenic Derivatives of Birch Pollen Evaluated.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Researchers in Sweden evaluated genetically engineered hypoallergenic derivatives of the major birch pollen allergen Bet v1. and determined they may have potential in specific immunotherapy. "Nearly 60%...

Radioimmunotherapy with 131-I-3F8 Monoclonal Antibody Reaches Phase I Trial.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Researchers in the United States presented promising preliminary results from a Phase I clinical trial of a radioimmunotherapy (RIT) procedure against GD2-positive leptomeningeal (LM) cancers using the...

Immunotherapy with Epratuzumab Demonstrates Clinical Efficacy.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Immunotherapy of non-Hodgkin's lymphoma (NHL) with epratuzumab, an anti-CD22 monoclonal antibody (MAb), has demonstrated excellent tolerability and clear clinical efficacy, according to recent study findings....

Adoptive Immunotherapy Reported Safe and Feasible.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Adoptive immunotherapy using anti-HER2/neu + anti-Fc gamma RI bispecific antibody in patients with ovarian cancer was safe and feasible, researchers in France and Belgium reported at a recent conference. ...

Novel Immunotherapy Fuses Cancer Cells to Dendritic Cells.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Researchers in the United States have fused human ovarian carcinoma cells to autologous or allogeneic dendritic cells (DCs) to induce antitumor immunity. "Human ovarian carcinomas express the CA-125,...

Researchers Discover Immune System Defect in Rheumatoid Arthritis Patients.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Mayo Clinic researchers in Rochester, Minnesota, have identified premature aging in the immune system of patients with rheumatoid arthritis, reversing earlier beliefs about the relationship between the immune...

Phase I SBIR Grant Received to Develop Lipid-Based Vaccines.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Aquila Biopharmaceuticals, Inc. (AQLA), Framingham, Massachusetts, announced that it has been awarded a grant from the U.S. National Institutes of Health (NIH) to support the development of novel vaccines to...

Participants Sought for Interleukin-2 Study for HIV/AIDS Immunotherapy.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Infectious disease researchers at Northwestern University Medical School and Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, are conducting a study of an investigational drug in patients with...

Experimental Monoclonal Antibody Could Help Patients with Refractory Disease.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- New study results suggest that an experimental drug could halve the number of asthma attacks suffered by people whose condition isn't well controlled with current treatment - about 15% of all asthma patients....

Magnetic Bead Immunoselection Process Removes Ewing's Sarcoma Cells.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Researchers in the United States have developed a magnetic bead immunoselection process that purges Ewing's sarcoma cells from autologous blood. "Ewing's sarcoma is a childhood tumor characterized by a...

Mycobacterium tuberculosis Ag38 Gene Cooperates with Interleukin 12 Against Tumors.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- A novel anticancer immunotherapy approach combines bacteria and cytokines in a vaccine vehicle. "An approach to stimulating an immune response against tumors is to transduce tumor cells with bacterial...

HIV Specific Unresponsiveness May Play Role in Diminished T-Cell Production.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- According to a study from the United States, anergy may be caused by the lack of CD4(+) T-cell proliferation to p24 antigen (Ag) in HIV infected individuals. "It has been suggested that CD4(+) T-cell...

HspE7 Phase II Trial in Cervical Cancer Initiated.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- StressGen Biotechnologies Corp. (SSB), Victoria, British Columbia, announced that it has initiated patient treatment in its Phase II clinical trial to investigate HspE7. HspE7 is an immunotherapeutic used...

Bacterial Protein Shows Promise for Cancer Vaccine.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- A non-toxic form of a bacterial protein known as Shiga B-subunit, together with tumor-associated molecules, can stimulate the immune system of mice to attack cancer cells without the need for secondary...

Chemoimmunotherapy is Important in Treating Advanced and Metastatic Disease.(renal cell carcinoma)
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Chemoimmunotherapy plays an important role in the successful treatment of advanced and metastatic renal cell carcinoma (RCC), say researchers in Poland. "RCC is usually treated with surgery and/or...

Gene Therapy Uses Vectors Encoding Cytokines or Cytokine Inhibitors.(for treatment of autoimmune disorders)
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Researchers in Canada have explored potential approaches for gene therapy of autoimmune disorders. "Gene therapy offers advantages for the immunotherapeutic delivery of cytokines or their inhibitors,"...

Combination Treatment Prevents T-Cell Tolerization in Lymphoma Model.(B7-1, interferon-gamma, and anti-cytotoxic T lymphocyte)
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Researchers in Belgium report that B7-1, interferon (IFN)-gamma, and anti-CTLA-4 acted cooperatively to prevent T-cell tolerization during immunotherapy of a murine model of lymphoma. "We previously...

Selenium Stimulates in vitro Production in Adult Blood Cells, Inhibits in Cord Blood Cells.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Selenium induces cytokine production in cord blood and adult blood cells in vitro, but inhibits the immune system proteins' production in cord blood cells. "We compared the production of some cytokines in...

Specific Immunotherapy Uses Attenuated Autologous Tumor Cells.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Active specific immunotherapy based on attenuated autologous tumor cells shows some responsiveness in patients with advanced stage melanoma, researchers in Brazil report. "From April 1998 to November...

Y-90-Zevalin Radioimmunotherapy Dosimetry Results Reported.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Results of Phase I/II multicenter clinical trials indicate that Y-90-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy administered at nonmyeloablative maximum tolerated doses is not...

Avonex Shows Effect on Primary Progressive MS.(multiple sclerosis)
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Biogen, Inc. (BGEN), Cambridge, Massachusetts, announced that Avonex (Interferon beta-1a) has shown potential to affect one of the most aggressive forms of multiple sclerosis (MS). In the first study to...

Genomic Target and Therapeutic Antibody Collaboration Announced.(Eos Biotechnology Inc. and Biogen Inc. form breast cancer therapy research venture)
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Eos Biotechnology, Inc. and Biogen, Inc. (BGEN), South San Francisco, California, announced the establishment of a multi-year research and development collaboration to identify targets for antibody and...

Dendritic Cell Vaccine Evaluated in Advanced Melanoma Patients.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Researchers in Italy evaluated a vaccine protocol based on dendritic cells (DC) pulsed with heat shock protein (HSP) or lysate from autologous tumor in patients with advanced melanoma. "A vaccination...

Immunocytokine Reaches Dose Escalation Studies.(Hu14.18-IL2 cancer immunotherapy immunocytokine)
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Researchers in the United States announced that the Hu14.18-IL2 immunocytokine designed for cancer immunotherapy has reached dose escalation studies. "Our research team has pursued preclinical and...

ACIS Test Development Expansion Used to Aid Patient Treatment.(Automated Cellular Imaging System)
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- ChromaVision Medical Systems, Inc. (CVSN), San Juan Capistrano, California, announced that it has begun development of three new Automated Cellular Imaging System (ACIS) tests that address a wide variety of...

Progressor Chimpanzees Could Reveal Mechanism for Resisting AIDS.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Three HIV positive chimpanzees that are progressing to AIDS could provide insight into how the disease develops and might be averted. This is according to research conducted at the Yerkes Regional Primate...

Infections Resistant to Interferon Alpha-2b Might Respond to High-Dose Interferon Alfacon-1.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- High-dose interferon alfacon-1 (Infergen, Amgen) given for 24 weeks in a recent study often cleared the hepatitis C virus (HCV) from the blood of infected patients for whom a conventional interferon-based...

Adoptive Transfer of Gene-Modified Cells Prolonged Survival in HIV Patients.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Adoptive transfer of gene-modified autologous CD4(+) and CD8(+) cells prolonged survival in HIV infected subjects, researchers in the United States reported. "We have genetically engineered CD4(+) and...

Treatment Increases Autoantibodies in Some HCV Patients.(hepatitis C virus)
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- According to researchers at the University of Padua in Italy, a small percentage of hepatitis C virus (HCV) patients will have increased autoantibodies for cells and hormones produced in the pancreas or the...

Alzheimer's Disease Collaboration Established.(between Roche Basel and MorphoSys AG)
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Roche Basel, Basel, Switzerland, and MorphoSys AG (MOR), Martinsried/Munich, announced the signing of an agreement under which the companies will collaborate on the development of human therapeutic antibodies...

Daclizumab and Triple Maintenance Immunosuppression Reduces Organ Rejection.(in kidney transplants)
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- According to data from a clinical trial in the United States, daclizumab and triple maintenance immunosuppression reduces the incidence of rejection in patients with kidney transplants. "Daclizumab (DAC)...

Combination Immunogene Therapy/Radiation Zaps Brain Metastases.(Great Poland Cancer Center researches genetically modified cellular cancer vaccine)
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Researchers in Poland find that a combination of immunogene therapy and radiation is well tolerated and relieves symptoms in melanoma patients with brain metastases. Sergiusz Nawrocki and colleagues at...

Study Supports Safety and Tolerability of Anti-Rejection Therapy.(Simulect, basilimimab, anti-rejection therapy research)
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Simulect (basiliximab), when combined with standard immunosuppressant drugs, has been shown to be a well-tolerated anti-rejection therapy for children who have received a kidney transplant. This is...

Mechanism Found Behind Drug-Free Acceptance of New Organs.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Scientists at Ohio State University may have discovered how a few rare organ transplant recipients manage to prevent their bodies from rejecting their new organs without the help of drugs. In this unusual...

Issuance of Two U.S. Patents on Vaccine Technology Announced.(Brief Article)
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Cel-Sci Corp. (CVM), Vienna, Virginia, announced the issuance of two U.S. patents expanding the patent protection related to Cel-Sci's Ligand Epitope Antigen Presentation System (LEAPS) vaccine technology....